Trial intelligence / Profile preview

PREVENIR-FIV: Multidisciplinary Platform for Environmental Reprotoxic Exposures in Subfertile Couples

NCT06100523Not yet recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Jan 2024
Primary completion
Jan 2026
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Clinical live birth rate at 24 months. Planned start Jan 2024; status: not yet recruiting.

Beyond the preview

Go deeper on NCT06100523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06100523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call